TCIM
AMAG

TIAA CREF Investment Management’s AMAG Pharmaceuticals AMAG Stock Holding History

TIAA CREF Investment Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2.22M Buy
172,687
+4,053
+2% +$60.4K ﹤0.01% 1949
2018
Q4 		$2.56M Buy
168,634
+5,994
+4% +$114K ﹤0.01% 1810
2018
Q3 		$3.25M Sell
162,640
-75,959
-32% -$1.73M ﹤0.01% 1865
2018
Q2 		$4.65M Buy
238,599
+12,211
+5% +$270K ﹤0.01% 1646
2018
Q1 		$4.56M Buy
226,388
+81,571
+56% +$1.38M ﹤0.01% 1607
2017
Q4 		$1.92M Sell
144,817
-12,621
-8% -$190K ﹤0.01% 2161
2017
Q3 		$2.9M Sell
157,438
-15,585
-9% -$290K ﹤0.01% 1943
2017
Q2 		$3.18M Buy
173,023
+49,209
+40% +$975K ﹤0.01% 1882
2017
Q1 		$2.79M Sell
123,814
-8,796
-7% -$211K ﹤0.01% 1937
2016
Q4 		$4.62M Buy
132,610
+5,214
+4% +$156K ﹤0.01% 1656
2016
Q3 		$3.12K Sell
127,396
-1,612
-1% -$40.3K ﹤0.01% 1906
2016
Q2 		$3.09M Buy
129,008
+13,122
+11% +$301K ﹤0.01% 1855
2016
Q1 		$2.71M Sell
115,886
-539
-0.5% -$12.8K ﹤0.01% 1913
2015
Q4 		$3.52M Sell
116,425
-390
-0.3% -$12.6K ﹤0.01% 1799
2015
Q3 		$4.64M Buy
116,815
+9,045
+8% +$561K ﹤0.01% 1583
2015
Q2 		$7.44M Buy
107,770
+17,742
+20% +$1.12M 0.01% 1370
2015
Q1 		$4.92M Buy
90,028
+8,170
+10% +$389K ﹤0.01% 1641
2014
Q4 		$3.49M Sell
81,858
-342
-0.4% -$12.4K ﹤0.01% 1882
2014
Q3 		$2.62M Sell
82,200
-4,900
-6% -$104K ﹤0.01% 2057
2014
Q2 		$1.8M Sell
87,100
-36,857
-30% -$681K ﹤0.01% 2361
2014
Q1 		$2.4M Hold
123,957
– – ﹤0.01% 2128
2013
Q4 		$3.01M Sell
123,957
-6,600
-5% -$155K ﹤0.01% 1993
2013
Q3 		$2.8M Sell
130,557
-8,699
-6% -$206K ﹤0.01% 1997
2013
Q2 		$3.1M Buy
+139,256
New +$3.07M ﹤0.01% 1880

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

TIAA CREF Investment Management's AMAG Position: Q1 2019 in Review

TIAA CREF Investment Management increased its AMAG Pharmaceuticals (AMAG) stake by 2.4% in Q1 2019, buying an estimated $60.4K and bringing the position to 172,687 shares worth $2.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1949.

TIAA CREF Investment Management first reported a position in AMAG in Q2 2013 and has held it in 24 quarters since. The position peaked at $7.44M in Q2 2015. 166 funds tracked by Wall St. Rank hold AMAG as of Q1 2019.

  • TIAA CREF Investment Management held 172,687 shares of AMAG Pharmaceuticals worth $2.22M as of Q1 2019.
  • TIAA CREF Investment Management bought 4,053 AMAG Pharmaceuticals shares in Q1 2019, an estimated $60.4K.
  • AMAG Pharmaceuticals made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1949 holding.
  • TIAA CREF Investment Management first reported a position in AMAG Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's AMAG Pharmaceuticals position peaked at $7.44M in Q2 2015.
  • 166 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.